Ephedra Label Warning With Limited PDP Statement Recommended By CRN
This article was originally published in The Tan Sheet
Executive Summary
The Council for Responsible Nutrition suggests FDA require a label warning format for ephedrine alkaloid-containing products featuring a limited principal display panel declaration that refers consumers to more information on another part of the label